ArticlePaediatric and perinatal epidemiology2026
Exploring the Impact of Missing Death Data on Identification of Congenital Malformations in Insurance Claims Data.
Article in Paediatric and perinatal epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundAccurate algorithms are needed to support real-world studies of medication safety in pregnancy. Kharbanda et al. developed and validated algorithms for congenital malformations that incorporate death data and diagnosis codes from the ICD-9-CM and ICD-10-CM coding eras.
objectivesTo modify an EHR-based malformation algorithm for use with claims data and quantify the impact of missing death by calculating prevalence and sensitivity.
methodsUsing the MarketScan Commercial Database (2007-2022), we established a linked cohort of birthing parents and their liveborn infants, and a claims subcohort restricted to years with inpatient death information. We established a cohort of liveborn infants in Kaiser Permanente Washington (KPWA) integrated EHR/claims data (2007-2022) that included comprehensive death information. We applied the validated algorithm to identify 22 malformations in MarketScan and 7 in KPWA (those with a prevalence ≥ 10 per 10,000 live births in MarketScan). In MarketScan, we calculated malformation prevalence with and without death information. We assessed the contribution of death on malformation identification by calculating sensitivity (with death as the gold standard).
resultsAmong 2,203,328 infants in the MarketScan cohort, malformation prevalence was 201.3 per 10,000 live births. In the MarketScan subcohort (n = 1,287,384), prevalence was 198.2 and 199.1 per 10,000 live births without and with death information, respectively. Among the most prevalent malformations, estimated sensitivity ranged from 95.8% for severe cardiac defects to 100.0% for intestinal atresia or stenosis, pyloric stenosis and limb deficiency (claims/EHR cohort) and from 98.6% for severe cardiac defects to 100.0% for intestinal atresia or stenosis and pyloric stenosis (claims subcohort). Limitations include the use of an imperfect gold standard and a lack of chart review.
conclusionsWe adapted a validated malformation algorithm for use with claims data. Omitting death information did not meaningfully impact sensitivity, suggesting this algorithm can be applied to data sources lacking death information.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.